One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papershttps://doi.org/10.1212/wnl.0000000000202912
Copy DOI Journal: Neurology |  Publication Date: Apr 25, 2023 |
Affiliation: UCB Pharma (Germany), University Health Network, UCB Pharma (United Kingdom), University of Lübeck, National Hospital Organization Hanamaki Hospital, University of South Florida, University of Copenhagen, UCB Pharma (Spain), George Washington University, Istituto Neurologico Carlo Besta, UCB Pharma (United States)Efficacy of Rozanolixizumab in Generalized Myasthenia Gravis: Subgroup Analyses from the Randomized Phase 3 MycarinG Study (S5.007)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
